Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Certara, Inc.

Market Cap 862M 751M 696M 651M 1.22B 81.32B 1.23B 8.26B 3.2B 40.03B 3.24B 3.17B 139B P/E 2026 *
-56.8x
P/E 2027 * -1,108x
Enterprise Value 937M 817M 756M 708M 1.33B 88.38B 1.34B 8.97B 3.48B 43.5B 3.52B 3.44B 151B EV / Sales 2026 *
2.35x
EV / Sales 2027 * 2.08x
Free-Float
69.31%
Yield 2026 *
-
Yield 2027 * -
1 day-8.13%
1 week+6.54%
Current month-4.81%
1 month+20.70%
3 months-13.17%
6 months-38.92%
Current year-37.12%
1 week 5.16
Extreme 5.16
6.24
1 month 4.57
Extreme 4.57
6.24
Current year 4.45
Extreme 4.45
10.2
1 year 4.45
Extreme 4.45
13.88
3 years 4.45
Extreme 4.45
19.87
5 years 4.45
Extreme 4.45
45.48
10 years 4.45
Extreme 4.45
45.48
Manager TitleAgeSince
Chief Executive Officer 53 2025-12-31
Director of Finance/CFO 53 2023-03-31
President 62 2023-07-31
Director TitleAgeSince
Chairman 72 2021-11-30
Director/Board Member 68 2012-12-31
Director/Board Member 59 2017-07-31
Date Insider Type Main position Quantity % Market Cap.
05-31Fiscal year

Head of Human Resources

16,535 0.0106%
05-31Fiscal year

General Counsel

57,763 0.0371%
05-13Fiscal year

Director

64,736 0.0422%
Change 5-day change 1-year change 3-year change Capi.($)
-8.13%+6.54%-47.59%-68.07% 862M
+0.13%-2.90%-21.00%+10.83% 2,818B
-1.65%+0.38%-8.21%+688.16% 308B
+14.20%+21.57%+285.88%+839.40% 140B
-0.57%+0.63%+30.50%+64.26% 107B
-1.35%+0.36%-3.82%+3.25% 87.22B
-1.60%-3.00%+71.49%+132.90% 79.38B
+0.48%+10.06%-41.37%+47.04% 55.91B
+4.93%+13.00%+0.33%+72.59% 44.43B
+7.31%+18.98%-49.80%+23.28% 36.89B
Average +1.37%+5.57%+21.64%+181.36% 367.8B
Weighted average by Cap. +0.56%-1.13%-4.69%+104.52%

Financials

2026 *2027 *
Net sales 399M 348M 322M 301M 565M 37.62B 569M 3.82B 1.48B 18.52B 1.5B 1.46B 64.3B 406M 354M 328M 307M 575M 38.3B 579M 3.89B 1.51B 18.85B 1.52B 1.49B 65.46B
Net income -16.71M -14.57M -13.49M -12.63M -23.69M -1.58B -23.83M -160M -62.04M -776M -62.72M -61.38M -2.69B -2.11M -1.84M -1.71M -1.6M -2.99M -199M -3.01M -20.24M -7.84M -98.1M -7.93M -7.76M -341M
Net Debt 74.77M 65.19M 60.38M 56.52M 106M 7.06B 107M 716M 278M 3.47B 281M 275M 12.06B -17.2M -14.99M -13.89M -13M -24.38M -1.62B -24.53M -165M -63.85M -799M -64.56M -63.17M -2.77B
Logo Certara, Inc.
Certara, Inc. is a provider of biosimulation technology and solutions for using Model-Informed Drug Development (MIDD) in the global biopharmaceutical industry. It accelerates medicine using biosimulation software, technology and services to transform traditional drug discovery and development. It delivers software products and technology-driven services to customers to carry out and realize the full benefits of biosimulation in drug discovery, preclinical and clinical research, regulatory submissions and market access. Its regulatory science and market access software and services, such as regulatory submissions software, natural language processing and Bayesian analytics. It offers both mechanistic and empirical biosimulation solutions, providing clients with a comprehensive offering based on their therapy goals, mechanism of action, and available data sources. Its clients include 2,600 biopharmaceutical companies, academic institutions and biotech companies across 70 countries.
Employees
1,546
Date Price Change Volume
26-06-18 5.540 $ -8.13% 7,909,792
26-06-17 6.030 $ -0.33% 4,206,863
26-06-16 6.050 $ +16.12% 7,111,920
26-06-15 5.210 $ +0.19% 4,205,619
26-06-12 5.200 $ -1.33% 3,267,330
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
5.540USD
Average target price
7.480USD
Spread / Average Target
+35.02%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CERT Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!